We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+9.47%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$2.08B
AUM Growth
+$273M
Cap. Flow
+$118M
Cap. Flow %
5.69%
Top 10 Hldgs %
26.49%
Holding
390
New
18
Increased
114
Reduced
180
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 36.53%
2 Technology 15.7%
3 Healthcare 10.65%
4 Financials 8.79%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LECO icon
351
Lincoln Electric
LECO
$15.5B
$238K 0.01%
1,710
AON icon
352
Aon
AON
$75.4B
$237K 0.01%
787
NAUT icon
353
Nautilus Biotechnolgy
NAUT
$113M
$235K 0.01%
+45,350
New +$243K
SCHK icon
354
Schwab 1000 Index ETF
SCHK
$5.88B
$233K 0.01%
+10,000
New +$227K
MRNA icon
355
Moderna
MRNA
$55.1B
$230K 0.01%
904
-50
-5% -$14.6K
LIN icon
356
Linde
LIN
$226B
$227K 0.01%
+655
New +$212K
IWP icon
357
iShares Russell Mid-Cap Growth ETF
IWP
$20.2B
$222K 0.01%
1,928
AVEM icon
358
Avantis Emerging Markets Equity ETF
AVEM
$28B
$220K 0.01%
+3,472
New +$224K
CMI icon
359
Cummins
CMI
$77.8B
$219K 0.01%
1,003
OGN icon
360
Organon & Co
OGN
$3.61B
$219K 0.01%
7,203
-1,068
-13% -$34.8K
EMN icon
361
Eastman Chemical
EMN
$8.35B
$218K 0.01%
+1,807
New +$201K
DUK icon
362
Duke Energy
DUK
$93.8B
$215K 0.01%
2,047
-100
-5% -$10.1K
KMI icon
363
Kinder Morgan
KMI
$70.3B
$215K 0.01%
13,526
-11,830
-47% -$197K
FNDF icon
364
Schwab Fundamental International Large Company Index ETF
FNDF
$26B
$213K 0.01%
6,563
+11
+0.2% +$363
KKR icon
365
KKR & Co
KKR
$97.6B
$209K 0.01%
+2,800
New +$207K
ON icon
366
ON Semiconductor
ON
$28.3B
$208K 0.01%
+3,061
New +$173K
SBAC icon
367
SBA Communications
SBAC
$20.3B
$202K 0.01%
+518
New +$182K
TCON
368
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$131K 0.01%
2,373
+350
+17% +$22.3K
IEZ icon
369
iShares US Oil Equipment & Services ETF
IEZ
$386M
$129K 0.01%
10,000
GRFS
370
Grifois
GRFS
$5.23B
$123K 0.01%
10,955
VTAK icon
371
Catheter Precision
VTAK
$724K
$107K 0.01%
7
SRTA
372
Strata Critical Medical Inc
SRTA
$528M
$88K ﹤0.01%
10,000
SIRI icon
373
SiriusXM
SIRI
$9.62B
$65K ﹤0.01%
1,030
FBIO icon
374
Fortress Biotech
FBIO
$92.4M
$50K ﹤0.01%
1,333
GERN icon
375
Geron
GERN
$970M
$48K ﹤0.01%
39,047

Similar funds

Dowling & Yahnke's Q4 2021 Portfolio in Review

As of Q4 2021, Dowling & Yahnke held 390 positions worth $2.08B, up 15% from $1.81B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Dowling & Yahnke deployed $118M of net new capital in Q4 2021, opening 18 new positions and adding to 114 existing holdings. Its largest new stake was Revvity: 140,556 shares worth $28.3M.

By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was iShares Semiconductor ETF, an estimated $1.72M trimmed.

  • Dowling & Yahnke's largest Q4 2021 buy was Revvity: 140,556 shares worth $28.3M.
  • Dowling & Yahnke added most to Vanguard Short-Term Bond ETF in Q4 2021, an estimated $30.1M increase.
  • Dowling & Yahnke's biggest Q4 2021 reduction was iShares Semiconductor ETF, cutting an estimated $1.72M.
  • Dowling & Yahnke fully exited ARK Innovation ETF in Q4 2021, selling an estimated $695K.
  • Dowling & Yahnke's ten largest holdings make up 26% of its $2.08B portfolio in Q4 2021.
  • Dowling & Yahnke opened 18 new positions and closed 13 in Q4 2021.
  • Dowling & Yahnke's portfolio value rose 15% quarter-over-quarter to $2.08B.

Based on Dowling & Yahnke's 13F filing for Q4 2021, filed 10 Feb 2022.